Hepatitis C-Drug Pipeline Analysis and Market Forecasts to 2016

GlobalData has released a pharmaceutical and healthcare report, "Hepatitis C-Drug Pipeline Analysis and Market Forecasts to 2016".
 
Oct. 25, 2010 - PRLog -- GlobalData has released a pharmaceutical and healthcare report, "Hepatitis C-Drug Pipeline Analysis and Market Forecasts to 2016". The report is an essential source of information and analysis on the global hepatitis C market. The report identifies the key trends shaping and driving the global hepatitis C market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to cause significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global hepatitis C sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

GlobalData forecasts the global hepatitis C market to grow at 9.8% annually for the next seven years to reach $8.5 billion by 2016. This growth is primarily attributed to high unmet need in the market which is expected to be served by strong pipeline candidates. The growth will be further supported by the prevalence of the disease. GlobalData has concluded that the global hepatitis C market is underserved by the current product options and so there is significant scope for new entrants to capture value from underserved segments. Designing products with curative properties, high safety profiles and better patient compliance is one of key challenges for this market and could provide a significant market share for any company.  

Scope
The scope of the report includes:
-Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016.
-Key geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
-Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include protease inhibitors, polymerase inhibitors, toll receptor agonists, drugs with interferon-like actions, HCV inhibitors and immunomodulators.
-Analysis of the current and future market competition in the global hepatitis C market. The key market players covered are Merck, Human Genome Sciences, Novartis, Vertex, Janssen, Mitsubishi, Tibotec and Roche.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
-Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future hepatitis C market.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global hepatitis C market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global hepatitis C market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global hepatitis C market landscape?-Identify, understand and capitalize.



Table of Contents
1 Table of contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Hepatitis C: Market Characterization 5
2.1 Overview 5
2.2 Hepatitis C Market Size 5
2.3 Hepatitis C Market Forecast and Compound Annual Growth Rate 6
2.4 Drivers and Barriers for Hepatitis C Market 7
2.4.1 Drivers 7
2.4.2 Restraints 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 9
3 Hepatitis C Market : Competitive Assessment 10
3.1 Overview 10
3.2 Strategic Competitor Assessment 10
3.2.1 PegIntron (Peginterferon alfa-2b) in combination with Rebetol (Ribavirin) 11
3.2.2 Pegasys (peginterferon alfa-2a) in combination with Copegus (Ribavirin) 13
3.2.3 Infergen (Interferon alfacon-1) 15
3.2.4 Intron A (Interferon alfa 2b) in combination with Rebetol (Ribavirin) 16
3.3 Key Takeaway 18
4 Hepatitis C Market: Pipeline Assessment 19
4.1 Overview 19
4.2 Strategic Pipeline Assessment 19
4.2.1 Technology Trends Analytical Framework 19
4.3 Hepatitis C-Promising Drugs under Clinical Development 21
4.4 Drugs under Clinical Development 21
4.4.1 Boceprevir (SCH 503034) 21
4.4.2 Zalbin (albinterferon alfa-2b) 22
4.4.3 Telaprevir ( VX 905) 24
4.4.4 RG 7128 26
4.5 Hepatitis C Market-Clinical Pipeline by Mechanism of Action 27
4.6 Hepatitis C Pipeline-Pipeline by Clinical Phases of Development 28
4.6.1 Hepatitis C Market-Phase III Clinical Pipeline 28
4.6.2 Hepatitis C Market-Phase II Clinical Pipeline 29
4.6.3 Hepatitis C Market-Phase I Clinical Pipeline 31
4.6.4 Hepatitis C Market-Preclinical Pipeline 33
4.6.5 Hepatitis C Market-Discovery 34
4.7 Discontinued/Suspended Drugs for Hepatitis C 35
4.8 Key Takeaway 36
5 Hepatitis C Market: Implications for Future Market Competition 37
6 Hepatitis C Market: Future Players in the Hepatitis C Market 38
6.1 Introduction 38
6.1.1 Merck & Co 38
6.1.2 F. Hoffmann-La Roche and Pharmasset 41
6.1.3 Human Genome Sciences and Novartis 44
6.1.4 Vertex Pharmaceuticals and Tibotec Pharmaceuticals 47
7 Hepatitis C Market: Appendix 52
7.1 Definitions 52
7.2 Abbreviations 52
7.3 Research Methodology 53
7.3.1 Coverage 54
7.3.2 Secondary Research 54
7.3.3 Forecasting 54
7.3.4 Primary Research 57
7.3.5 Expert Panels 57
7.4 Contact Us 57
...

# # #

ChinaCCM.com is China's leading industry consultancy expert offering industry intelligence and research solution, ChinaCCM Market Research Centre is a research division focusing on professional market survey and industry research.
End
Email:***@chinaccm.com Email Verified
Zip:100022
Industry:Medical
Location:Beijing - China



Like PRLog?
9K2K1K
Click to Share